Increase in cell motility by carbon ion irradiation via the Rho signaling pathway and its inhibition by the ROCK inhibitor Y-27632 in lung adenocarcinoma A549 cells

J Radiat Res. 2014 Jul;55(4):658-64. doi: 10.1093/jrr/rru002. Epub 2014 Mar 21.

Abstract

This study aimed to investigate the effect of carbon ion (C-ion) irradiation on cell motility through the ras homolog gene family member (Rho) signaling pathway in the human lung adenocarcinoma cell line A549. Cell motility was assessed by a wound-healing assay, and the formation of cell protrusions was evaluated by F-actin staining. Cell viability was examined by the WST-1 assay. The expression of myosin light chain 2 (MLC2) and the phosphorylation of MLC2 at Ser19 (P-MLC2-S19) were analyzed by Western blot. At 48 h after irradiation, the wound-healing assay demonstrated that migration was significantly greater in cells irradiated with C-ion (2 or 8 Gy) than in unirradiated cells. Similarly, F-actin staining showed that the formation of protrusions was significantly increased in cells irradiated with C-ion (2 or 8 Gy) compared with unirradiated cells. The observed increase in cell motility due to C-ion irradiation was similar to that observed due to X-ray irradiation. Western-blot analysis showed that C-ion irradiation (8 Gy) increased P-MLC2-S19 expression compared with in unirradiated controls, while total MLC2 expression was unchanged. Exposure to a non-toxic concentration of Y-27632, a specific inhibitor of Rho-associated coiled-coil-forming protein kinase (ROCK), reduced the expression of P-MLC2-S19 after C-ion irradiation (8 Gy), resulting in a significant reduction in migration. These data suggest that C-ion irradiation increases cell motility in A549 cells via the Rho signaling pathway and that ROCK inhibition reduces that effect.

Keywords: Rho-associated coiled-coil-forming protein kinase (ROCK); carbon ion (C-ion) irradiation; cell motility; non-small cell lung carcinoma (NSCLC); ras homolog gene family member (Rho).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / metabolism
  • Adenocarcinoma / pathology
  • Adenocarcinoma / radiotherapy*
  • Adenocarcinoma of Lung
  • Amides / pharmacology
  • Cardiac Myosins / metabolism
  • Cell Line, Tumor
  • Cell Movement / physiology
  • Cell Movement / radiation effects*
  • Enzyme Inhibitors / pharmacology
  • Heavy Ion Radiotherapy / adverse effects*
  • Humans
  • Lung Neoplasms / metabolism
  • Lung Neoplasms / pathology
  • Lung Neoplasms / radiotherapy*
  • Myosin Light Chains / metabolism
  • Pyridines / pharmacology
  • Signal Transduction / radiation effects
  • rho GTP-Binding Proteins / metabolism
  • rho-Associated Kinases / antagonists & inhibitors
  • rho-Associated Kinases / metabolism

Substances

  • Amides
  • Enzyme Inhibitors
  • Myosin Light Chains
  • Pyridines
  • myosin light chain 2
  • Y 27632
  • rho-Associated Kinases
  • Cardiac Myosins
  • rho GTP-Binding Proteins